OR WAIT null SECS
Click here to read the articles and download the PDF
A conversation with Matthew Bardell, managing director, nVentic, about a perhaps overlooked but useful strategic component of company performance and overall business benchmarks: inventory optimization.
Making sense of the accelerating trends and challenges—including store closings, pharmacy deserts, and the rise of polypharmacy.
Even as pharma technology evolves, and payers argue over reimbursement practices throughout healthcare, drug wholesaling is a thriving business.
November 29, 2023
Pharma Commerce editor takes a look back at 2023's impressionable editorial content.
November 28, 2023
Biden Administration invokes Defense Production Act to facilitate domestic manufacturing of essential medicines.
Studies explore how both the UK and EU are handling these ongoing supply chain challenges.
The approval of Ogsiveo represents an important therapeutic advance for patients with progressing desmoid tumors requiring systemic treatment.
Investigation notes a need for greater transparency in 340B program revenue and strengthened enforcement authority for the Health Resources and Services Administration.
The designation—which ranks the fastest-growing companies in North America—is powered by AeroSafe’s 477% growth rate.
November 27, 2023
AbbVie and Genmab will share commercial responsibilities in the United States and Japan for epcoritamab-bysp (Epkinly) for the treatment of adults with follicular lymphoma that is relapsed or refractory following treatment with two or more therapies.
Alladapt Immunotherapeutics said the FDA Fast Track designation highlights the importance of developing a treatment for multiple food allergens.
November 22, 2023
Study aims to find ways industry gets involved in the most influential clinical trials, and how transparent these trials are.
The CDMO’s GMP plant will dedicate 2,500 square feet to the storage of finished products.